ResearchMoz

Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

GBI Research
Published Date » 2012-12-14
No. Of Pages » 49
     
  Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes  
     
  Summary  
   
 GBI Research, the leading business intelligence provider, has released its latest research report: Mobile Health (mHealth) Enhancing Healthcare and Improving Clinical Outcomes. The report examines how mHealth, which is the facilitation of health-related information through mobile-enabled technologies, has been applied by the pharmaceutical industry in drug development and by healthcare providers in the developed and emerging economies to improve healthcare services and treatment outcomes. 
   
 It looks in detail at the ways in which the pharmaceutical industry has utilized mobile technologies in patient recruitment, compliance and retention of clinical trials, its role...
Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 7
2.1 What is mHealth? 7
2.2 mHealth Aims 8
2.3 Stakeholder Groups Involved in the Funding and Provision of mHealth 9
2.4 Role of mHealth Technologies in the Pharmaceutical Industry 10
2.5 Key Market Segments in the mHealth Space 10
2.5.1 Mobile Health - Mobile Network Operators 10
2.5.2 Mobile Health - Pharmaceutical Industry 10
2.5.3 Mobile Health - Healthcare Professionals 11
2.5.4 Mobile Health - Healthcare Providers 11
2.5.5 Mobile Health - Consumers 11

3 mHealth in Drug Development 12
3.1 Introduction 12
3.2 Mobile Health in Pharmaceutical R&D 13
3.3 Patient Recruitment in Clinical Trials 14
3.3.1 Case Study: REMOTE (Pfizer) 14
3.3.2 Social Media 14
3.4 Patient Compliance and Retention in Clinical Trials 16
3.5 Safety Data Collection 17
3.6 Consumer Education 18
3.7 Mobile Medical Education 18
3.8 Drug Authentication 19
3.9 Post-market Surveillance 20

4 mHealth in Healthcare 21
4.1 Introduction 21
4.2 Electronic Personal Health Records 21
4.3 Electronic Health Records and Medical Records 22
4.3.1 Electronic Health Records and Observational Studies 22
4.4 Clinical Decision Support Systems 23
4.4.1 Case Study: Epocrates 23
4.5 Mobile Healthcare for Healthcare Providers 24
4.5.1 Prescribable Apps 25
4.5.2 Virtual Consultations 25
4.6 Recent Innovations in Medical Diagnostics 26
4.7 Barriers to mHealth Implementation 27

5 Transforming Healthcare in the Emerging Economies through mHealth 28
5.1 Introduction 28
5.2 Shortage of Medical Resources 29
5.3 Improving the Flow of Health Information 30
5.4 Role of the mHealth Alliance 31
5.5 mHealth Applications in the Emerging Economies 32
5.6 Disease Surveillance 33
5.7 Education and Awareness 35
5.7.1 Mobile Technology for Community Health 35
5.7.2 iTEACH 35
5.8 Healthcare Information Management Systems 37
5.9 Health Financing 38
5.10 Patient Monitoring and Support 38
5.11 Point-of-care Services 40
5.12 Barriers to mHealth Implementation in the Emerging Economies 42
5.13 Overall Conclusions 42

6 Appendix 43
6.1 Acronyms 43
6.2 Bibliography 44
6.3 Terminology 48
6.4 Methodology 48
6.4.1 Primary Research 48
6.4.2 Secondary Research 49
6.5 Contact Us 49
6.6 Disclaimer 49

List of Tables


Table 1: mHealth Disease Surveillance Programs 34
Table 2: mHealth Education and Awareness Programs 36
Table 3: mHealth Health Information Management Systems Programs 37
Table 4: mHealth Patient Monitoring and Support Programs 38
Table 5: mHealth Point-of-care Programs 41

List of Figures


Figure 1: mHealth Services 7
Figure 2: Key Stakeholders in the Provision of Funding to Drive mHealth Forward 9
Figure 3: Potential Application of mHealth by the Pharmaceutical Industry 13
Figure 4: Impact of Social Media on Phase III Recruitment of Diabetic Neuropathy Trial, 2011 15
Figure 5: Exco InTouch Services 16
Figure 6: PharmaSecure Drug Authentication Mobile App 19
Figure 7: Innovative Healthcare Software Platforms 20
Figure 8: Mobile Patient Communication Software 24
Figure 9: Patient Perception of how mHealth will Change Healthcare 28
Figure 10: Cell phone Subscriptions per 100 Inhabitants, 2001-2011 29
Figure 11: mHealth Applications in the Emerging Economies 30
Figure 12: mHealth Initiatives in Member States, by WHO region, 2011 32

Upcoming Reports:

Low Voltage and Medium Voltage Motors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Motor is a device which converts electrical energy into mechanical energy or motion to drive electrical equipment. Electric motors are used in various applications such as, blowers and pumps, power tools, disk drives, industrial fans, machine tools, and household appliances. In addition, high voltage motors are used in pipeline compression, ship propulsion and pumped-storage. Low voltage motors include energy-saving, motors according to NEMA standards, explosion-protected, N-compact standardline, marine and smoke extraction motors. Medium voltage motors include asynchronous squirrel-cage,...
Plywood Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Plywood is a wood panel prepared from thin sheets of wood veneer. Plywood is one of the most widely used wood products. It is inexpensive, flexible, re-usable and workable. Plywood is used as a substitute for plain wood due to its resistance to cracking, splitting, shrinkage and twisting. Plywood generally offers higher degree of strength than plain wood. On the basis of applications plywood is classified as softwood plywood, hardwood plywood, tropical plywood and decorative plywood among others.  The market for plywood was mainly driven by increasing demand from housing...
Gene Amplification Technologies Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018
By - Transparency Market Research
Gene amplification technology is proving to be an important technology in human genome projects and other important fields like diagnostics. There are number of companies involved in the business of gene amplification and diagnostics with over 30 gene and signal amplification technologies. These gene amplification technologies are used for variety of applications in research and clinical settings.  Currently, the market for gene amplification technologies is forecast to increase to $2.2 billion over the year 2017. This growth is expected to be driven by successful...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...